Clinical Trial Update: PV-10 vs Chemotherapy or Oncolytic Viral Therapy for Treatment of Locally Advanced Cutaneous Melanoma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing PV-10 to chemotherapy or oncolytic viral therapy for locally advanced cutaneous melanoma was terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Melanoma

Drugs mentioned

• PV-10 (Rose Bengal disodium)

Snippet

Sponsor: Provectus Biopharmaceuticals, Inc. | Conditions: Cutaneous Melanoma | Phase 3 | Status: TERMINATED | Results posted: 2022-01-19